Developing a Risk-scoring Model for Ankylosing Spondylitis Based on a Combination of HLA-B27, Single-nucleotide Polymorphism, and Copy Number Variant Markers.
Developing a Risk-scoring Model for Ankylosing Spondylitis Based on a Combination of HLA-B27, Single-nucleotide Polymorphism, and Copy Number Variant Markers.
J Rheumatol. 2017 Jan;44(1):132
Authors:
PMID: 28042135 [PubMed - in process]
Source: J Rheumatol - Category: Rheumatology Tags: J Rheumatol Source Type: research
More News: Ankylosing Spondylitis | Rheumatology